Intervention Delivery Matters: What Mothers at High Risk for Type 2 Diabetes Want in a Diabetes Prevention Program—Results from a Comparative Effectiveness Trial

Kelly N.B. Palmer; Valene E. Garr Barry; David G. Marrero; Brett M. McKinney; Anne N. Graves; Chelsy K. Winters; Tamara S. Hannon

doi:10.1007/s13300-020-00891-1

Intervention Delivery Matters: What Mothers at High Risk for Type 2 Diabetes Want in a Diabetes Prevention Program—Results from a Comparative Effectiveness Trial

Kelly N.B. Palmer
, Valene E. Garr Barry
, David G. Marrero
, Brett M. McKinney
, Anne N. Graves
, Chelsy K. Winters
, Tamara S. Hannon

Research output: Contribution to journal › Article › peer-review

8 Scopus citations

Abstract

Participants in the ENCOURAGE Healthy Families Study, a family-focused, modified Diabetes Prevention Program, reported challenges to and preferences for engaging in a diabetes prevention program. Challenges with flexible intervention delivery, accessibility, the traditional group-based format, and Coronavirus Disease 2019 (COVID-19) exposure risk can be mitigated by participant preferences for one-on-one, virtual/online intervention delivery. Trial Registration: ClinicalTrials.gov identifier, NCT01823367.

Original language	English (US)
Pages (from-to)	2411-2418
Number of pages	8
Journal	Diabetes Therapy
Volume	11
Issue number	10
DOIs	https://doi.org/10.1007/s13300-020-00891-1
State	Published - Oct 1 2020
Externally published	Yes

Keywords

COVID-19
Gestational diabetes
Lifestyle intervention
Prediabetes
Primary prevention
Type 2 diabetes

ASJC Scopus subject areas

Internal Medicine
Endocrinology, Diabetes and Metabolism

Access to Document

10.1007/s13300-020-00891-1

Cite this

@article{9d45f342a8d742f8a979ca2b9a9ee37c,

title = "Intervention Delivery Matters: What Mothers at High Risk for Type 2 Diabetes Want in a Diabetes Prevention Program—Results from a Comparative Effectiveness Trial",

abstract = "Participants in the ENCOURAGE Healthy Families Study, a family-focused, modified Diabetes Prevention Program, reported challenges to and preferences for engaging in a diabetes prevention program. Challenges with flexible intervention delivery, accessibility, the traditional group-based format, and Coronavirus Disease 2019 (COVID-19) exposure risk can be mitigated by participant preferences for one-on-one, virtual/online intervention delivery. Trial Registration: ClinicalTrials.gov identifier, NCT01823367.",

keywords = "COVID-19, Gestational diabetes, Lifestyle intervention, Prediabetes, Primary prevention, Type 2 diabetes",

author = "Palmer, \{Kelly N.B.\} and \{Garr Barry\}, \{Valene E.\} and Marrero, \{David G.\} and McKinney, \{Brett M.\} and Graves, \{Anne N.\} and Winters, \{Chelsy K.\} and Hannon, \{Tamara S.\}",

note = "Publisher Copyright: {\textcopyright} 2020, The Author(s).",

year = "2020",

month = oct,

day = "1",

doi = "10.1007/s13300-020-00891-1",

language = "English (US)",

volume = "11",

pages = "2411--2418",

journal = "Diabetes Therapy",

issn = "1869-6953",

publisher = "Springer Publishing Company",

number = "10",

}

TY - JOUR

T1 - Intervention Delivery Matters

T2 - What Mothers at High Risk for Type 2 Diabetes Want in a Diabetes Prevention Program—Results from a Comparative Effectiveness Trial

AU - Palmer, Kelly N.B.

AU - Garr Barry, Valene E.

AU - Marrero, David G.

AU - McKinney, Brett M.

AU - Graves, Anne N.

AU - Winters, Chelsy K.

AU - Hannon, Tamara S.

PY - 2020/10/1

Y1 - 2020/10/1

N2 - Participants in the ENCOURAGE Healthy Families Study, a family-focused, modified Diabetes Prevention Program, reported challenges to and preferences for engaging in a diabetes prevention program. Challenges with flexible intervention delivery, accessibility, the traditional group-based format, and Coronavirus Disease 2019 (COVID-19) exposure risk can be mitigated by participant preferences for one-on-one, virtual/online intervention delivery. Trial Registration: ClinicalTrials.gov identifier, NCT01823367.

AB - Participants in the ENCOURAGE Healthy Families Study, a family-focused, modified Diabetes Prevention Program, reported challenges to and preferences for engaging in a diabetes prevention program. Challenges with flexible intervention delivery, accessibility, the traditional group-based format, and Coronavirus Disease 2019 (COVID-19) exposure risk can be mitigated by participant preferences for one-on-one, virtual/online intervention delivery. Trial Registration: ClinicalTrials.gov identifier, NCT01823367.

KW - COVID-19

KW - Gestational diabetes

KW - Lifestyle intervention

KW - Prediabetes

KW - Primary prevention

KW - Type 2 diabetes

UR - https://www.scopus.com/pages/publications/85089155830

UR - https://www.scopus.com/pages/publications/85089155830#tab=citedBy

U2 - 10.1007/s13300-020-00891-1

DO - 10.1007/s13300-020-00891-1

M3 - Article

SN - 1869-6953

VL - 11

SP - 2411

EP - 2418

JO - Diabetes Therapy

JF - Diabetes Therapy

IS - 10

ER -

Intervention Delivery Matters: What Mothers at High Risk for Type 2 Diabetes Want in a Diabetes Prevention Program—Results from a Comparative Effectiveness Trial

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this